Condensed Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid- In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2022	$ 420,278	$ 7	$ 997,111	$ (8,032)	$ (568,808)
Beginning balance (in shares) at Dec. 31, 2022		68,314
Share-based compensation expense	6,838		6,838
Issuance of common stock under equity plans (in shares)		125
Other comprehensive income	2,136			2,136
Net loss	(34,069)				(34,069)
Ending balance at Mar. 31, 2023	395,183	$ 7	1,003,949	(5,896)	(602,877)
Ending balance (in shares) at Mar. 31, 2023		68,439
Beginning balance at Dec. 31, 2023	397,273	$ 7	1,119,976	(1,271)	(721,439)
Beginning balance (in shares) at Dec. 31, 2023		74,350
Issuance of pre-funded warrants to purchase common stock, net of offering costs	122,726		122,726
Issuance of common stock, net of offering costs	23,088	$ 1	23,087
Issuance of common stock, net of offering costs, (in shares)		1,377
Share-based compensation expense	8,512		8,512
Issuance of common stock under equity plans	2,555		2,555
Issuance of common stock under equity plans (in shares)		454
Other comprehensive income	455			455
Net loss	(49,525)				(49,525)
Ending balance at Mar. 31, 2024	$ 505,084	$ 8	$ 1,276,856	$ (816)	$ (770,964)
Ending balance (in shares) at Mar. 31, 2024		76,181